文献速递免疫规划卫生政策与健康促进

利用社交媒体构建COVID-19疫苗信心:四国全国性活动的发现与经验

How to leverage social media to build confidence in COVID-19 vaccines: findings and lessons learned from nationwide campaigns in four countries.
PubMed 文献 · Vaccine · 2026-03-25

疫苗犹豫仍是全球健康挑战,削弱常规免疫和COVID-19疫苗的接种。与联合国儿童基金会国家办事处的战略合作是将行为洞察转化为有效传播策略的关键。

要点

  • 基于证据和情境设计的信息可提升疫苗信心态度。
  • 本地语言信息在促进信息寻求行为方面表现更好。
  • 与联合国儿童基金会国家办事处合作有助于转化行为洞察。

核心结论

  • 该研究提供了可复制的流程,供地方卫生机构采用以加强数字社交与行为改变传播。

研究设计与样本

  • 四国研究,采用基于证据、情境驱动的说服性信息设计与随机对照测试流程。

主要发现

  • 信息成功改变了疫苗信心态度。
  • 本地语言活动在鼓励信息寻求行为(点击率)方面表现更好。

临床怎么用

  • 地方卫生机构可采用该流程设计数字社交与行为改变传播。
  • 与联合国儿童基金会国家办事处建立战略合作,将行为洞察转化为有效传播策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccine hesitancy remains a global health challenge, undermining gains in routine immunization coverage and the uptake of COVID-19 vaccines worldwide. Effective, responsive health communication is needed to counter 'infodemics' and strengthen public trust in vaccination. Evidence on how to design effective digital campaigns to strengthen vaccine demand is limited, particularly in low- and middle-income countries. Results from this four-country study demonstrate a process for the design and randomized controlled testing of evidence-based, context-driven persuasive messaging to strengthen vaccine demand. Campaigns led to 3.5 M+ clicks to additional resources, and messages were successful at shifting attitudes toward vaccine confidence, with campaigns in local languages performing better in encouraging information-seeking behavior (clickthrough rate). Strategic partnership with UNICEF country offices was key to convert behavioral insights into effective communication strategies. This work provides a replicable process that local health agencies can adopt to strengthen their digital social and behavior change communications.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. James E, Christie S, Boye B, et al. How to leverage social media to build confidence in COVID-19 vaccines: findings and lessons learned from nationwide campaigns in four countries. Vaccine. 2026. PMID: 41887021. doi:10.1016/j.vaccine.2026.128475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。